scholarly journals Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease

2007 ◽  
Vol 33 (3) ◽  
pp. 169-173 ◽  
Author(s):  
Z. Master ◽  
M. McLeod ◽  
I. Mendez
2012 ◽  
Vol 3 (2) ◽  
pp. 11 ◽  
Author(s):  
Stuart AJ Gibson ◽  
Guo-Dong Gao ◽  
Katya McDonagh ◽  
Sanbing Shen

2002 ◽  
Vol 249 (0) ◽  
pp. 1-1 ◽  
Author(s):  
M. Gerlach ◽  
H. Braak ◽  
A. Hartmann ◽  
W. H. Jost ◽  
P. Odin ◽  
...  

2005 ◽  
Vol 32 (06) ◽  
Author(s):  
GU Höglinger ◽  
P Rizk ◽  
WH Oertel ◽  
EC Hisch

2021 ◽  
Vol 22 (3) ◽  
pp. 1154
Author(s):  
Yong-Ren Chen ◽  
Pei-Lun Lai ◽  
Yueh Chien ◽  
Po-Hui Lee ◽  
Ying-Hsiu Lai ◽  
...  

The authors regret to have made a mistake in publishing this paper [...]


2021 ◽  
pp. 1-6
Author(s):  
Asuka Morizane ◽  
Jun Takahashi

Stem cell-based therapies for Parkinson’s disease are now being applied clinically. Notably, studies have shown that controlling the graft-induced immune response improves the results. In this mini-review, we concisely summarize current approaches used for this control. We focus on four modes of stem cell-based therapies: autologous transplantation, allogeneic transplantation with human leukocyte antigen-matching and allogeneic transplantation without, and finally the application of “universal” pluripotent stem cells. We also discuss immuno-suppressive treatments and the monitoring of immune reactions in the brain.


Sign in / Sign up

Export Citation Format

Share Document